Concepedia

Joseph Raybon

JR

Statistics

Publications

11

Citations

403

H-Index

11

Active since

2003

Affiliations

Bristol-Myers Squibb (United States)(Current)

Pfizer (United States)

University at Buffalo, State University of New York

GlaxoSmithKline (United States)

Teva Pharmaceuticals (United States)

Joseph Raybon is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

2003–2017

11

Publications

11

Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors

Guanglin Luo, Ling Chen, Catherine R. Burton et al. · Journal of Medicinal Chemistry · 2016 · 68 citations · Full text

, , +16

Pharmacodynamics of Selective Inhibition of γ-Secretase by Avagacestat

Charles F. Albright, Randy Dockens, Jere E. Meredith et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 63 citations

Preclinical Pharmacokinetic/Pharmacodynamic Modeling and Simulation in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape

Edgar Schuck, Tonika Bohnert, Arijit Chakravarty et al. · The AAPS Journal · 2015 · 51 citations · Full text

, , +9

The γ-Secretase Modulator, BMS-932481, Modulates Aβ Peptides in the Plasma and Cerebrospinal Fluid of Healthy Volunteers

Holly Soares, Maciej Gąsior, Jeremy H. Toyn et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 45 citations · Full text

Neuroinflammatory Role of Prostaglandins during Experimental Meningitis: Evidence Suggestive of an in Vivo Relationship between Nitric Oxide and Prostaglandins

Kathleen M.K. Boje, David Jaworowicz, Joseph Raybon · Journal of Pharmacology and Experimental Therapeutics · 2003 · 40 citations

1–5 of 11